SynCore Biotechnology Co.,Ltd (TPEX:4192)

Taiwan · Delayed Price · Currency is TWD

20.10

+0.10 (0.50%)

Mar 4, 2026, 12:52 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
New Drug Development	23.34M	20.20M	15.86M	6.94M	13.34M
New Drug Development Growth	15.55%	27.36%	128.52%	-47.97%	2.85%
Total	23.34M	20.20M	15.86M	6.94M	13.34M
Total Growth	15.55%	27.36%	128.52%	-47.97%	2.85%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Taiwan	23.34M	20.20M	15.86M	6.94M	13.34M
Taiwan Growth	15.55%	27.36%	128.52%	-47.97%	-
Total	23.34M	20.20M	15.86M	6.94M	13.34M
Total Growth	15.55%	27.36%	128.52%	-47.97%	-

Source: S&P Global Market Intelligence.